SMMT stock

Summit Therapeutics PLC (SMMT) financials · $11.46B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Summit Therapeutics PLC (SMMT) $11.46B cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/AN/A
Operating IncomeN/A-$226.0M
Net Income-$1.08B-$221.3M
EPS (Diluted)-$1.44-$0.31
Cached annual balance sheet
LineFY2025FY2024
Total Assets$751.2M$435.6M
Current Assets$720.3M$423.8M
Cash & Equivalents$225.3M$104.9M
PP&E$1.06M$254.0K
Total Liabilities$92.3M$46.8M
Current Liabilities$73.0M$41.7M
Shareholders' Equity$658.9M$388.7M
Retained Earnings-$2.29B-$1.21B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$322.9M-$142.1M
CapEx$657.0K$139.0K
Investing Cash Flow-$174.3M-$205.3M
Financing Cash Flow$617.5M$381.2M
Net Change in Cash$120.4M$33.8M
Free Cash Flow-$323.6M-$142.2M
These statements as JSON? API free 100/day

FAQ

What is SMMT P/E and revenue?

Summit Therapeutics PLC (SMMT) $11.46B cap.

What is SMMT revenue?

SMMT income-statement cache has no revenue figure yet.

Is SMMT profitable?

Summit Therapeutics PLC last cached net income is -$1.08B (FY2025).

What are SMMT total assets?

Summit Therapeutics PLC last cached total assets are $751.2M (FY2025).

What is SMMT free cash flow?

Summit Therapeutics PLC last cached free cash flow is -$323.6M (FY2025).

Not investment advice. Cached statements, not a live tape.